BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36294804)

  • 1. Depressive Pseudodementia with Reversible AD-like Brain Hypometabolism: A Case Report and a Review of the Literature.
    Pozzi FE; Licciardo D; Musarra M; Jonghi-Lavarini L; Crivellaro C; Basso G; Appollonio I; Ferrarese C
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
    Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
    J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential trajectories of hypometabolism across cognitively-defined Alzheimer's disease subgroups.
    Groot C; Risacher SL; Chen JQA; Dicks E; Saykin AJ; Mac Donald CL; Mez J; Trittschuh EH; Mukherjee S; Barkhof F; Scheltens P; van der Flier WM; Ossenkoppele R; Crane PK;
    Neuroimage Clin; 2021; 31():102725. PubMed ID: 34153688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Behavioral/Dysexecutive Variant of Alzheimer's Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization.
    Bergeron D; Sellami L; Poulin S; Verret L; Bouchard RW; Laforce R
    Dement Geriatr Cogn Disord; 2020; 49(5):518-525. PubMed ID: 33207355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional neuroimaging using F-18 FDG PET/CT in amnestic mild cognitive impairment: A preliminary study.
    Tripathi M; Tripathi M; Sharma R; Jaimini A; Md'souza M; Saw S; Mondal A; Kushwaha S
    Indian J Nucl Med; 2013 Jul; 28(3):129-33. PubMed ID: 24250019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
    Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
    Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain metabolic signatures across the Alzheimer's disease spectrum.
    Sala A; Caprioglio C; Santangelo R; Vanoli EG; Iannaccone S; Magnani G; Perani D
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):256-269. PubMed ID: 31811345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
    Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Wabik A; Trypka E; Bladowska J; Statkiewicz M; Sąsiadek M; Zimny A
    J Transl Med; 2022 Jun; 20(1):259. PubMed ID: 35672750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of cingulate-precuneus-temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease.
    Isella V; Crivellaro C; Formenti A; Musarra M; Pacella S; Morzenti S; Ferri F; Mapelli C; Gallivanone F; Guerra L; Appollonio I; Ferrarese C
    J Neurol; 2022 Aug; 269(8):4440-4451. PubMed ID: 35347453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.
    Habeck C; Risacher S; Lee GJ; Glymour MM; Mormino E; Mukherjee S; Kim S; Nho K; DeCarli C; Saykin AJ; Crane PK;
    Brain Imaging Behav; 2012 Dec; 6(4):568-83. PubMed ID: 23179062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
    Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
    Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
    Lehmann M; Ghosh PM; Madison C; Karydas A; Coppola G; O'Neil JP; Huang Y; Miller BL; Jagust WJ; Rabinovici GD
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):266-73. PubMed ID: 23965289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
    Fujishiro H; Iseki E; Murayama N; Yamamoto R; Higashi S; Kasanuki K; Suzuki M; Arai H; Sato K
    Psychogeriatrics; 2010 Sep; 10(3):144-52. PubMed ID: 20860570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain metabolic patterns in patients with suspected non-Alzheimer's pathophysiology (SNAP) and Alzheimer's disease (AD): is [
    Chiaravalloti A; Barbagallo G; Martorana A; Castellano AE; Ursini F; Schillaci O
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1796-1805. PubMed ID: 31201430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.